@angtaykor taurx's finish line seems to be always pushed back

@clarachan I think some analyst expect genting to double if taurx is successful. But I largely think it depends on which country approves and how much they can sell the drug for

From what I've read so far, Taurx seems to have the superior drug compared to its competitors.

The main problem it's having is getting commercial approval from the major health bodies.

My concern is that it migjt end up being another Novovax...too late to the race